REFERENCES
451.
Idvall J, Ahlgren I, Aronsen KR, Stenberg P:
Ketamine infusions: Pharmacokinetics and clinical effects. Br J Anaesth 51:1167–1173,
1979.
452.
Nimmo W, Clements J: Ketamine. In
Prys-Robert CH (ed): Pharmacokinetics of Anesthesia. Boston, Blackwell, 1984, p
235.
453.
White PF, Marietta MP, Pudwill CR, et al: Effects
of halothane anesthesia on the biodisposition of ketamine in rats. J Pharmacol Exp
Ther 196:545–555, 1976.
454.
Edwards SR, Minto CF, Mather LE: Concurrent ketamine
and alfentanil administration: Pharmacokinetic considerations. Br J Anaesth 88:94–100,
2002.
455.
Geisslinger G, Hering W, Thomann P, et al: Pharmacokinetics
and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective
analytical method. Br J Anaesth 70:666–671, 1993.
456.
Schuttler J, Stanski DR, White PF, et al: Pharmacodynamic
modeling of the EEG effects of ketamine and its enantiomers in man. J Pharmacokinet
Biopharm 15:241–253, 1987.
457.
Taylor PA, Towey RM: Depression of laryngeal
reflexes during ketamine anaesthesia. BMJ 2:688–689, 1971.
458.
Grant IS, Nimmo WS, McNicol LR, Clements JA:
Ketamine disposition in children and adults. Br J Anaesth 55:1107–1111, 1983.
459.
Corssen G, Domino EF: Dissociative anesthesia:
Further pharmacologic studies and first clinical experience with the phencyclidine
derivative CI-581. Anesth Analg 45:29–40, 1966.
460.
Corssen G, Miyasaka M, Domino EF: Changing concepts
in pain control during surgery: Dissociative anesthesia with CI-581. A progress
report. Anesth Analg 47:746–759, 1968.
461.
Adams HA, Thiel A, Jung A, et al: Studies using
S-(+)-ketamine on probands. Endocrine and circulatory reactions, recovery and dream
experiences [in German]. Anaesthesist 41:588–596, 1992.
462.
Kharasch ED, Labroo R: Metabolism of ketamine
stereoisomers by human liver microsomes. Anesthesiology 77:1201–1217, 1992.
463.
Domino E, Chodoff P, Corssen G: Pharmacologic
effects of CI-581, a new dissociative anesthetic in man. Clin Pharmacol Ther 6:279–291,
1965.
464.
Okamoto GU, Duperon DF, Jedrychowski JR: Clinical
evaluation of the effects of ketamine sedation on pediatric dental patients. J Clin
Pediatr Dent 16:253–257, 1992.
465.
Doenicke A, Kugler J, Mayer M, et al: Ketamine
racemate or S-(+)-ketamine and midazolam. The effect on vigilance, efficacy and
subjective findings [in German]. Anaesthesist 41:610–618, 1992.
466.
Chapman V, Dickenson AH: The combination of NMDA
antagonism and morphine produces profound antinociception in the rat dorsal horn.
Brain Res 573:321–323, 1992.
467.
Kissin I, Bright CA, Bradley EL Jr: The effect
of ketamine on opioid-induced acute tolerance: Can it explain reduction of opioid
consumption with ketamine-opioid analgesic combinations? Anesth Analg 91:1483–1488,
2000.
468.
Menigaux C, Fletcher D, Dupont X, et al: The
benefits of intraoperative small-dose ketamine on postoperative pain after anterior
cruciate ligament repair. Anesth Analg 90:129–135, 2000.
469.
Guignard B, Coste C, Costes H, et al: Supplementing
desflurane-remifentanil anesthesia with small-dose ketamine reduces perioperative
opioid analgesic requirements. Anesth Analg 95:103–108, 2002.
470.
Miyasaka M, Domino E: Neural mechanisms of ketamine-induced
anesthesia. Int J Neuropharmacol 7:557–573, 1968.
471.
Massopust LC Jr, Wolin LR, Albin MS: Electrophysiologic
and behavioral responses to ketamine hydrochloride in the Rhesus monkey. Anesth
Analg 51:329–341, 1972.
472.
Sparks DL, Corssen G, Aizenman B, Black J: Further
studies of the neural mechanisms of ketamine-induced anesthesia in the rhesus monkey.
Anesth Analg 54:189–195, 1975.
473.
Ohtani M, Kikuchi H, Kitahata LM, et al: Effects
of keta-mine on nociceptive cells in the medial medullary reticular formation of
the cat. Anesthesiology 51:414–417, 1979.
474.
Frenkel C, Urban BW: Molecular actions of racemic
ketamine on human CNS sodium channels. Br J Anaesth 69:292–297, 1992.
475.
Finck A, Ngai S: A possible mechanism of ketamine-induced
analgesia. Anesthesiology 51:S34, 1979.
476.
Fratta W, Casu M, Balestrieri A, et al: Failure
of ketamine to interact with opiate receptors. Eur J Pharmacol 61:389–391,
1980.
477.
Freye E, Latasch L, Schmidhammer H: Pharmacodynamic
effects of S-(+)-ketamine on EEG, evoked potentials and respiration. A study in
the awake dog [in German]. Anaesthesist 41:527–533, 1992.
478.
Irifune M, Shimizu T, Nomoto M, Fukuda T: Ketamine-induced
anesthesia involves the N-methyl-D-aspartate
receptor-channel complex in mice. Brain Res 596:1–9, 1992.
479.
Klepstad P, Maurset A, Moberg ER, Oye I: Evidence
of a role for NMDA receptors in pain perception. Eur J Pharmacol 187:513–518,
1990.
480.
Oye I, Paulsen O, Maurset A: Effects of ketamine
on sensory perception: Evidence for a role of N-methyl-D-aspartate
receptors. J Pharmacol Exp Ther 260:1209–1213, 1992.
481.
Nagasaka H, Nagasaka I, Sato I, et al: The effects
of keta-mine on the excitation and inhibition of dorsal horn WDR neuronal activity
induced by bradykinin injection into the femoral artery in cats after spinal cord
transection. Anesthesiology 78:722–732, 1993.
482.
Kayama Y, Iwama K: The EEG, evoked potentials,
and single-unit activity during ketamine anesthesia in cats. Anesthesiology 36:316–328,
1972.
483.
Gardner AE, Dannemiller FJ, Dean D: Intracranial
cerebrospinal fluid pressure in man during ketamine anesthesia. Anesth Analg 51:741–745,
1972.
484.
Shapiro HM, Wyte SR, Harria AB: Ketamine anaesthesia
in patients with intracranial pathology. Br J Anaesth 44:1200–1204, 1972.
485.
Dawson B, Michenfelder JD, Theye RA: Effects
of ketamine on canine cerebral blood flow and metabolism: Modification by prior
administration of thiopental. Anesth Analg 50:443–447, 1971.
486.
Thorsen T, Gran L: Ketamine/diazepam infusion
anaesthesia with special attention to the effect on cerebrospinal fluid pressure
and arterial blood pressure. Acta Anaesthesiol Scand 24:1–4, 1980.
487.
Reeker W, Werner C, Mollenberg O, et al: High-dose
S(+)-ketamine improves neurological outcome following incomplete cerebral ischemia
in rats. Can J Anaesth 47:572–578, 2000.
488.
Engelhard K, Werner C, Eberspacher E, et al:
The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate
antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after
incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 96:524–531,
2003.
489.
Garfield JM, Garfield FB, Stone JG, et al: A
comparison of psychologic responses to ketamine and thiopental-nitrous oxide-halothane
anesthesia. Anesthesiology 36:329–338, 1972.
490.
Sussman DR: A comparative evaluation of ketamine
anesthesia in children and adults. Anesthesiology 40:459–464, 1974.
491.
Dundee JW, Bovill JG, Clarke RS, Pandit SK: Problems
with ketamine in adults. Anaesthesia 26:86, 1971.
492.
Khorramzadeh E, Lotfy AO: Personality predisposition
and emergence phenomena with ketamine. Psychosomatics 17:94–95, 1976.
493.
Kumar A, Bajaj A, Sarkar P, Grover VK: The effect
of music on ketamine induced emergence phenomena. Anaesthesia 47:438–439,
1992.
494.
Hejja P, Galloon S: A consideration of ketamine
dreams. Can Anaesth Soc J 22:100–105, 1975.
495.
Wulfsohn NL: Ketamine dosage for induction based
on lean body mass. Anesth Analg 51:299–305, 1972.
496.
Johnstone M: The prevention of ketamine dreams.
Anaesth Intensive Care 1:70–74, 1972.
497.
Dundee JW, Lilburn JK: Ketamine-lorazepam: Attenuation
of the psychic sequelae of ketamine by lorazepam. Anaesthesia 37:312–314,
1977.
498.
Kothary S, Zsigmond E: A double-blind study of
the effective anti-hallucinatory doses of diazepam prior to ketamine anesthesia.
Clin Pharmacol Ther 21:108, 1977.
499.
Doenicke A, Angster R, Mayer M, et al: The action
of S-(+)-ketamine on serum catecholamine and cortisol. A comparison with ketamine
racemate [in German]. Anaesthesist 41:597–603, 1992.
500.
Soliman MG, Brinale GF, Kuster G: Response to
hypercapnia under ketamine anaesthesia. Can Anaesth Soc J 22:486–494, 1975.
501.
Virtue RW, Alanis JM, Mori M, et al: An anesthetic
agent: 2-Orthochlorophenyl, 2-methylamino cyclohexanone HCl (CI-581). Anesthesiology
28:823–833, 1967.
502.
Stanley V, Hunt J, Willis KW, Stephen CR: Cardiovascular
and respiratory function with CI-581. Anesth Analg 47:760–768, 1968.
503.
Dillon J: Clinical experience with repeated ketamine
administration for procedures requiring anesthesia. In
Kreuscher H (ed): Ketamine. Berlin, Springer-Verlag, 1969.
504.
Hamza J, Ecoffey C, Gross JB: Ventilatory response
to CO2
following intravenous ketamine in children. Anesthesiology 70:422–425,
1989.
505.
Greene CA, Gillette PC, Fyfe DA: Frequency of
respiratory compromise after ketamine sedation for cardiac catheterization in patients
less than 21 years of age. Am J Cardiol 68:1116–1117, 1991.
506.
Huber FC Jr, Gutierrez J, Corssen G: Ketamine:
Its effect on airway resistance in man. South Med J 65:1176–1180, 1972.
507.
Corssen G, Gutierrez J, Reves JG, Huber FC Jr:
Ketamine in the anesthetic management of asthmatic patients. Anesth Analg 51:588–596,
1972.
508.
Hirshman CA, Downes H, Farbood A, Bergman NA:
Ketamine block of bronchospasm in experimental canine asthma. Br J Anaesth 51:713–718,
1979.
509.
Wanna HT, Gergis SD: Procaine, lidocaine, and
ketamine inhibit histamine-induced contracture of guinea pig tracheal muscle in vitro.
Anesth Analg 57:25–27, 1978.
510.
Sarma VJ: Use of ketamine in acute severe asthma.
Acta Anaesthesiol Scand 36:106–107, 1992.
511.
Sonntag H, Heiss HW, Knoll D, et al: Myocardial
perfusion and myocardial oxygen consumption in patients during the induction of anesthesia
using dehydrobenzperidol-fentanyl or ketamine [in German]. Z Kreislaufforsch 61:1092–1105,
1972.
512.
Zsigmond E, Domino E: Clinical pharmacology and
current uses of ketamine. In Aldrete J, Stanley
T (eds): Trends in Intravenous Anesthesia. Chicago, Year Book, 1980, p 283.
513.
Savage TM, Colvin MP, Weaver EJ, et al: A comparison
of some cardiorespiratory effects of althesin and ketamine when used for induction
of anaesthesia in patients with cardiac disease. Br J Anaesth 48:1071–1081,
1976.
514.
Gooding JM, Dimick AR, Tavakoli M, Corssen G:
A physiologic analysis of cardiopulmonary responses to ketamine anesthesia in noncardiac
patients. Anesth Analg 56:813–816, 1977.
515.
Reves JG, Lell WA, McCracken LE Jr, et al: Comparison
of morphine and ketamine anesthetic techniques for coronary surgery: A randomized
study. South Med J 71:33–36, 1978.
516.
Spotoft H, Korshin JD, Sorensen MB, Skovsted P:
The cardiovascular effects of ketamine used for induction of anaesthesia in patients
with valvular heart disease. Can Anaesth Soc J 26:463–467, 1979.
517.
Morray JP, Lynn AM, Stamm SJ, et al: Hemodynamic
effects of ketamine in children with congenital heart disease. Anesth Analg 63:895–899,
1984.
518.
Greeley WJ, Bushman GA, Davis DP, Reves JG: Comparative
effects of halothane and ketamine on systemic arterial oxygen saturation in children
with cyanotic heart disease. Anesthesiology 65:666–668, 1986.
519.
Faithfull NS, Haider R: Ketamine for cardiac
catheterisation. An evaluation of its use in children. Anaesthesia 26:318–323,
1971.
520.
Hickey PR, Hansen DD, Cramolini GM, et al: Pulmonary
and systemic hemodynamic responses to ketamine in infants with normal and elevated
pulmonary vascular resistance. Anesthesiology 62:287–293, 1985.
521.
Slogoff S, Allen GW: The role of baroreceptors
in the cardiovascular response to ketamine. Anesth Analg 53:704–707, 1974.
522.
Dowdy EG, Kaya K: Studies of the mechanism of
cardiovascular responses to CI-581. Anesthesiology 29:931–943, 1968.
523.
Chodoff P: Evidence for central adrenergic action
of ketamine: Report of a case. Anesth Analg 51:247–250, 1972.
524.
Wong DH, Jenkins LC: An experimental study of
the mechanism of action of ketamine on the central nervous system. Can Anaesth Soc
J 21:57–67, 1974.
525.
Iwatsuki, K, Aoba Y, Sato K, Iwatsuki N: Clinical
study on CI-581, a phencyclidine derivative. Tohoku J Exp Med 93:39–48, 1967.
526.
Ogawa A, Uemura M, Kataoka Y, et al: Effects
of ketamine on cardiovascular responses mediated by N-methyl-D-aspartate
receptor in the rat nucleus tractus solitarius. Anesthesiology 78:163–167,
1993.
527.
Ivankovich AD, Miletich DJ, Reimann C, et al:
Cardiovascular effects of centrally administered ketamine in goats. Anesth Analg
53:924–933, 1974.
528.
Zsigmond E, Kothary S, Matsuki A: Diazepam for
prevention of the rise in plasma catecholamines caused by ketamine. Clin Pharmacol
Ther 15:223, 1974.
529.
Balfors E, Haggmark S, Nyhman H, et al: Droperidol
inhibits the effects of intravenous ketamine on central hemodynamics and myocardial
oxygen consumption in patients with generalized atherosclerotic disease. Anesth
Analg 62:193–197, 1983.
530.
Miletich DJ, Ivankovic AD, Albrecht RF, et al:
The effect of ketamine on catecholamine metabolism in the isolated perfused rat
heart. Anesthesiology 39:271–277, 1973.
531.
Valicenti JF Jr, Newman WH, Bagwell EE, et al:
Myocardial contractility during induction and steady-state ketamine anesthesia.
Anesth Analg 52:190–194, 1973.
532.
Pagel PS, Kampine JP, Schmeling WT, Warltier DC:
Ketamine depresses myocardial contractility as evaluated by the preload recruitable
stroke work relationship in chronically instrumented dogs with autonomic nervous
system blockade. Anesthesiology 76:564–572, 1992.
533.
Urthaler F, Walker AA, James TN: Comparison of
the inotropic action of morphine and ketamine studied in canine cardiac muscle.
J Thorac Cardiovasc Surg 72:142–149, 1976.
534.
Stowe DF, Bosnjak ZJ, Kampine JP: Comparison
of etomidate, ketamine, midazolam, propofol, and thiopental on function and metabolism
of isolated hearts. Anesth Analg 74:547–558, 1992.
535.
Endou M, Hattori Y, Nakaya H, et al: Electrophysiologic
mechanisms responsible for inotropic responses to ketamine in guinea pig and rat
myocardium. Anesthesiology 76:409–418, 1992.
536.
Hill GE, Wong KC, Shaw CL, et al: Interactions
of ketamine with vasoactive amines at normothermia and hypothermia in the isolate
rabbit heart. Anesthesiology 48:315–319, 1978.
537.
Nedergaard OA: Cocaine-like effect of ketamine
on vascular adrenergic neurones. Eur J Pharmacol 23:153–161, 1973.
538.
Salt PJ, Barnes PK, Beswick FJ: Inhibition of
neuronal and extraneuronal uptake of noradrenaline by ketamine in the isolated perfused
rat heart. Br J Anaesth 51:835–838, 1979.
539.
Cook DJ, Housmans PR, Rorie DK: Effect of ketamine
HCl on norepinephrine disposition in isolated ferret ventricular myocardium. J Pharmacol
Exp Ther 261:101–107, 1992.
540.
Reves J, Flezzani P, Kissin I: Pharmacology of
intravenous anesthetic induction drugs. In Kaplan
J (ed): Cardiac Anesthesia. Orlando, FL, Grune & Stratton, 1987, p 125.
541.
Munro HM, Sleigh JW, Paxton LD: The cardiovascular
response to ketamine: The effects of clonidine and lignocaine. Acta Anaesthesiol
Scand 37:75–78, 1993.
542.
Hatano S, Keane DM, Boggs RF, et al: Diazepam-ketamine
anaesthesia for open heart surgery: A "micro-mini" drip administration technique.
Can J Anaesth 23:648–656, 1976.
543.
Bidwai AV, Stanley HT, Graves CL, et al: The
effects of ketamine on cardiovascular dynamics during halothane and enflurane anesthesia.
Anesth Analg 54:588–592, 1975.
544.
Corssen G, Reves JG, Carter JR: Neuroleptanesthesia,
dissociative anesthesia, and hemorrhage. Int Anesthesiol Clin 12:145–161,
1974.
545.
Van der Linden P, Gilbart E, Engelman E, et al:
Comparison of halothane, isoflurane, alfentanil, and ketamine in experimental septic
shock. Anesth Analg 70:608–617, 1990.
546.
Kingston HG, Bretherton KW, Holloway AM, Downing
JW: A comparison between ketamine and diazepam as induction agents for pericardiectomy.
Anaesth Intensive Care 6:66–70, 1978.
547.
Allen GC, Byford LJ, Shamji FM: Anterior mediastinal
mass in a patient susceptible to malignant hyperthermia. Can J Anaesth 40:46–49,
1993.
548.
Fletcher JE, Rosenberg H, Lizzo FH: Effects of
droperidol, haloperidol and ketamine on halothane, succinylcholine and caffeine contractures:
Implications for malignant hyperthermia. Acta Anaesthesiol Scand 33:187–192,
1989.
549.
Dershwitz M, Sreter FA, Ryan JF: Ketamine does
not trigger malignant hyperthermia in susceptible swine. Anesth Analg 69:501–503,
1989.
550.
Raza SM, Masters RW, Zsigmond EK: Haemodynamic
stability with midazolam-ketamine-sufentanil analgesia in cardiac surgical patients.
Can J Anaesth 36:617–623, 1989.
551.
Kudoh A, Takahira Y, Katagai H, Takazawa T: Small-dose
ketamine improves the postoperative state of depressed patients. Anesth Analg 95:114–118,
2002.
552.
Dich-Nielsen JO, Svendsen LB, Berthelsen P: Intramuscular
low-dose ketamine versus pethidine for postoperative pain treatment after thoracic
surgery. Acta Anaesthesiol Scand 36:583–587, 1992.
553.
Jahangir SM, Islam F, Aziz L: Ketamine infusion
for postoperative analgesia in asthmatics: A comparison with intermittent meperidine.
Anesth Analg 76:45–49, 1993.
554.
Weinbroum AA: A single small dose of postoperative
ketamine provides rapid and sustained improvement in morphine analgesia in the presence
of morphine-resistant pain. Anesth Analg 96:789–795, 2003.
555.
Sveticic G, Gentilini A, Eichenberger U, et al:
Combinations of morphine with ketamine for patient-controlled analgesia: A new
optimization method. Anesthesiology 98:1195–1205, 2003.
556.
Eisenach JC, Yaksh TL: Epidural ketamine in healthy
children—what's the point? Anesth Analg 96:626, author reply 627, 2003.
557.
Groeneveld A, Inkson T: Ketamine. A solution
to procedural pain in burned children. Can Nurse 88:28–31, 1992.
558.
Wolfe RR, Loehr JP, Schaffer MS, Wiggins JW Jr:
Hemodynamic effects of ketamine, hypoxia and hyperoxia in children with surgically
treated congenital heart disease residing greater than or equal to 1,200 meters above
sea level. Am J Cardiol 67:84–87, 1991.
559.
Thompson GE, Moore DC: Ketamine, diazepam, and
Innovar: A computerized comparative study. Anesth Analg 50:458–463, 1971.
560.
Korttila K, Levanen J: Untoward effects of ketamine
combined with diazepam for supplementing conduction anaesthesia in young and middle-aged
adults. Acta Anaesthesiol Scand 22:640–648, 1978.
561.
Friedberg BL: Propofol-ketamine technique. Aesthetic
Plast Surg 17:297–300, 1993.
562.
Fuchs C, Schwabe M: Rectal premedication using
ketamine-dehydrobenzperidol-atropine in childhood [in French]. Anaesthesiol Reanim
15:322–326, 1990.
563.
Waxman K, Shoemaker WC, Lippmann M: Cardiovascular
effects of anesthetic induction with ketamine. Anesth Analg 59:355–358, 1980.
564.
Yang CY, Wong CS, Chang JY, Ho ST: Intrathecal
ketamine reduces morphine requirements in patients with terminal cancer pain. Can
J Anaesth 43:379–383, 1996.
565.
Weber F, Wulf H: Caudal bupivacaine and s(+)-ketamine
for postoperative analgesia in children. Paediatr Anaesth 13:244–248, 2003.
566.
Hui TW, Short TG, Hong W, et al: Additive interactions
between propofol and ketamine when used for anesthesia induction in female patients.
Anesthesiology 82:641–648, 1995.
567.
Gutstein HB, Johnson KL, Heard MB, Gregory GA:
Oral ketamine preanesthetic medication in children. Anesthesiology 76:28–33,
1992.
568.
Tobias JD, Phipps S, Smith B, Mulhern RK: Oral
ketamine premedication to alleviate the distress of invasive procedures in pediatric
oncology patients. Pediatrics 90:537–541, 1992.
569.
Neckel W, Jacobs FE, Tolksdorf W: Oral ketamine
as preferred preanesthetic medication of uncooperative patients [in German]. Anasthesiol
Intensivmed Notfallmed Schmerzther 27:381–384, 1992.
570.
Shapiro HM: Intracranial hypertension: Therapeutic
and anesthetic considerations. Anesthesiology 43:445–471, 1971.
571.
Thiel A, Adams HA, Fengler G, Hempelmann G: Studies
using S-(+)-ketamine on probands. Computerized EEG-analysis and transcranial Doppler
ultrasonography [in German]. Anaesthesist 41:604–609, 1992.
572.
Tsai SK, Lee C: Ketamine potentiates nondepolarizing
neuromuscular relaxants in a primate. Anesth Analg 68:5–8, 1989.
573.
Malinovsky JM, Lepage JY, Cozian A, et al: Is
ketamine or its preservative responsible for neurotoxicity in the rabbit? Anesthesiology
78:109–115, 1993.
574.
Godefroi EF, Janssen PA, Vandereycken CA, et al:
DL-1-(1-arylalkyl)imidazole-5-carboxylate esters: A novel type of hypnotic agents.
J Med Chem 8:220–223, 1965.
575.
Doenicke A: Etomidate, a new intravenous hypnotic.
Acta Anaesthesiol Belg 25:307–315, 1974.
576.
Janssen P, Niemegeers J, Schellekens K: Etomidate,
R-(+)-ethyl-1-(alpha-methyl-benzyl)imidazole-5-carboxylate (R 16659): A potent,
short-acting and relatively atoxic intravenous hypnotic agent in rats. Arzneimittelforschung
21:1234–1243, 1971.
577.
Ledingham IM, Watt I: Influence of sedation on
mortality in critically ill multiple trauma patients. Lancet 1:1270, 1983.
578.
Wagner RL, White PF: Etomidate inhibits adrenocortical
function in surgical patients. Anesthesiology 61:647–651, 1984.
579.
Longnecker DE: Stress free: To be or not to
be? Anesthesiology 61:643–644, 1984.
580.
Owen H, Spence AA: Etomidate. Br J Anaesth 56:555–557,
1984.
581.
Etomidate. Lancet 2:24–25, 1983.
582.
Corssen G, Reves J, Stanley T: Etomidate. In
Corssen G, Reves J Stanley T (eds): Intravenous Anesthesia and Analgesia. Philadelphia,
Lea & Febiger, 1988, p 285.
583.
Nimmo W, Miller M: Pharmacology of etomidate.
In Brown B (ed): New Pharmacologic Vistas in Anesthesia.
Philadelphia, FA Davis, 1983, p 83.
584.
Doenicke A, Roizen MF, Nebauer AE, et al: A comparison
of two formulations for etomidate, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and propylene
glycol. Anesth Analg 79:933–939, 1994.
585.
Hadzija BW, Lubarsky DA: Compatibility of etomidate,
thiopental sodium, and propofol injections with drugs commonly administered during
induction of anesthesia. Am J Health Syst Pharm 52:997–999, 1995.
586.
Fragen RJ, Caldwell N: Comparison of a new formulation
of etomidate with thiopental—side effects and awakening times. Anesthesiology
50:242–244, 1979.
587.
Carli F, Stribley GC, Clark MM: Etomidate infusion
in thoracic anaesthesia. Anaesthesia 38:784–788, 1983.
588.
Nauta J, Stanley TH, de Lang S, et al: Anaesthetic
induction with alfentanil: Comparison with thiopental, midazolam, and etomidate.
Can J Anaesth 30:53–60, 1983.
589.
Dundee J, Zacharias M: Etomidate. In
Dundee J (ed): Current Topics in Anaesthesia, Series 1. London, Arnold, 1979, p
46.
590.
Famewo CE, Odugbesan CO: Further experience with
etomidate. Can Anaesth Soc J 25:130–132, 1978.
591.
Giese JL, Stockham RJ, Stanley TH, et al: Etomidate
versus thiopental for induction of anesthesia. Anesth Analg 64:871–876, 1985.
592.
Craig J, Cooper GM, Sear JW: Recovery from day-case
anaesthesia. Comparison between methohexitone, Althesin and etomidate. Br J Anaesth
54:447–451, 1982.
593.
Wells JK: Comparison of ICI 35868, etomidate
and methohexitone for day-case anaesthesia. Br J Anaesth 57:732–735, 1985.
594.
Zacharias M, Dundee JW, Clarke RS, Hegarty JE:
Effect of preanaesthetic medication on etomidate. Br J Anaesth 51:127–133,
1979.
595.
Linton DM, Thornington RE: Etomidate as a rectal
induction agent. Part II: A clinical study in children. S Afr Med J 64:309–310,
1983.
596.
Schuttler J, Schwilden H, Stoekel H: Pharmacokinetics
as applied to total intravenous anaesthesia. Practical implications. Anaesthesia
38(Suppl):53–56, 1983.
597.
Sear JW, Walters FJ, Wilkins DG, Willatts SM:
Etomidate by infusion for neuroanaesthesia. Kinetic and dynamic interactions with
nitrous oxide. Anaesthesia 39:12–18, 1984.
598.
Van Hamme MJ, Ghoneim MM, Ambre JJ: Pharmacokinetics
of etomidate, a new intravenous anesthetic. Anesthesiology 49:274–277, 1978.
599.
Meuldermans WE, Heykants JJ: The plasma protein
binding and distribution of etomidate in dog, rat and human blood. Arch Int Pharmacodyn
Ther 221:150–162, 1976.
600.
Johnson KB, Egan TD, Layman J, et al: The influence
of hemorrhagic shock on etomidate: A pharmacokinetic and pharmacodynamic analysis.
Anesth Analg 96:1360–1368, 2003.
